Looking at Healthcare Trust of America's (NYSE:HR) mostly flat share price movement over the past three months, it is easy to think that there's nothing interesting about the stock. However, its financials look weak which could potentially mean that its stock could show weakness in the future given that stock performances are usually attached to a company's financial health in the long-term. Specifically, we decided to study Healthcare Trust of America's ROE in this article.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
See our latest analysis for Healthcare Trust of America
How To Calculate Return On Equity?
ROE can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for Healthcare Trust of America is:
2.9% = US$96m ÷ US$3.3b (Based on the trailing twelve months to March 2022).
The 'return' is the yearly profit. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.03.
Why Is ROE Important For Earnings Growth?
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
Healthcare Trust of America's Earnings Growth And 2.9% ROE
As you can see, Healthcare Trust of America's ROE looks pretty weak. Not just that, even compared to the industry average of 6.5%, the company's ROE is entirely unremarkable. Hence, the flat earnings seen by Healthcare Trust of America over the past five years could probably be the result of it having a lower ROE.
As a next step, we compared Healthcare Trust of America's net income growth with the industry and discovered that the industry saw an average growth of 11% in the same period.
NYSE:HR Past Earnings Growth July 23rd 2022
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is HR fairly valued? This infographic on the company's intrinsic value has everything you need to know.
Is Healthcare Trust of America Using Its Retained Earnings Effectively?
While the company did pay out a portion of its dividend in the past, it currently doesn't pay a dividend. We infer that the company has been reinvesting all of its profits to grow its business.
Conclusion
In total, we would have a hard think before deciding on any investment action concerning Healthcare Trust of America. As a result of its low ROE and lack of much reinvestment into the business, the company has seen a disappointing earnings growth rate. That being so, the latest industry analyst forecasts show that the analysts are expecting to see a huge improvement in the company's earnings growth rate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
看看美國醫療信託公司(NYSE：HR)過去三個月基本持平的股價走勢，很容易認為這隻股票沒有什麼有趣的東西。然而，該公司的財務狀況看起來很疲軟，這可能意味着，鑑於股票表現通常與一家公司的長期財務健康狀況有關，該公司的股票未來可能會表現出疲軟。具體地説，我們決定在本文中研究美國淨資產收益率的醫療信託。
股本回報率或淨資產收益率是股東要考慮的一個重要因素，因為它告訴他們他們的資本再投資的效率。簡而言之，它是用來評估一家公司相對於其權益資本的盈利能力。
查看我們對美國醫療信託基金的最新分析
如何計算股本回報率？
可使用以下公式計算淨資產收益率：
股本回報率=(持續經營的)淨利潤？股東權益
因此，根據上述公式，美國醫療信託基金的淨資產收益率為：
2.9%=9600萬美元×33億美元(基於截至2022年3月的12個月的往績)。
“回報”就是年度利潤。因此，這意味着股東每投資1美元，公司就會產生0.03美元的利潤。
為什麼淨資產收益率對收益增長很重要？
到目前為止，我們已經瞭解到淨資產收益率衡量的是一家公司創造利潤的效率。我們現在需要評估公司將多少利潤再投資或“保留”用於未來的增長，這就讓我們對公司的增長潛力有了一個瞭解。假設其他條件相同，與沒有相同特徵的公司相比，擁有更高股本回報率和更高利潤保留率的公司通常會有更高的增長率。
美國醫療信託的收益增長和2.9%的淨資產收益率
正如你所見，美國淨資產收益率(ROE)的醫療信託基金看起來相當疲軟。不僅如此，即使與6.5%的行業平均水平相比，該公司的淨資產收益率也完全不起眼。因此，過去五年美國醫療信託基金的收益持平，可能是因為它的淨資產收益率較低。
作為下一步，我們將美國醫療信託公司的淨收入增長與該行業進行了比較，發現該行業在同一時期的平均增長為11%。
紐約證券交易所：HR過去的收益增長2022年7月23日
賦予一家公司價值的基礎在很大程度上與其盈利增長掛鈎。投資者應該嘗試確定預期的收益增長或下降是否已計入價格，無論是哪種情況。通過這樣做，他們將知道股票是將進入清澈的藍色水域，還是等待沼澤水域。人力資源是否得到公平的評價？這張關於公司內在價值的信息圖包含了你需要知道的一切。
美國醫療信託基金是否有效地利用其留存收益？
雖然該公司過去確實支付了一部分股息，但目前不支付股息。我們推斷，該公司一直在將所有利潤進行再投資，以發展業務。
結論
總而言之，在決定對美國醫療信託公司採取任何投資行動之前，我們將經過深思熟慮。由於淨資產收益率較低，對該業務的再投資不足，該公司的收益增長率令人失望。既然如此，最新的行業分析師預測顯示，分析師們預計該公司的收益增長率將大幅提高。要了解更多有關該公司未來收益增長預測的信息，請查看以下內容免費報告分析師對該公司的預測，以瞭解更多信息。
對這篇文章有什麼反饋嗎？擔心內容嗎？ 保持聯繫直接與我們聯繫。或者，也可以給編輯組發電子郵件，地址是implywallst.com。
本文由Simply Wall St.撰寫，具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論，我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議，也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意，我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
